Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Andrew Blauvelt(Oregon Medical Research Center), Marjolein de Bruin‐Weller(University Medical Center Utrecht), Melinda Gooderham(Queen's University), Jennifer Clay Cather, Jamie Weisman(Advanced Pharma), David M. Pariser(Eastern Virginia Medical School), Eric L. Simpson(Oregon Health & Science University), Kim Papp(Probity Medical Research), Hyuck-Ki Hong(University of British Columbia), Diana Rubel(Australian National University), Peter Foley(The University of Melbourne), Errol P. Prens(Erasmus MC), C.E.M. Griffiths(Manchester Academic Health Science Centre), Takafumi Etoh, Pedro Herranz(Hospital Universitario La Paz), Ramón M. Pujol(Hospital Del Mar), Jacek C. Szepietowski, Karel Ettler, Lajos Kemény(University of Szeged), Xiaoping Zhu(Regeneron (United States)), Bolanle Akinlade(Regeneron (United States)), Thomas Hultsch(Sanofi (United States)), Vera Mastey(Regeneron (United States)), Abhijit Gadkari(Regeneron (United States)), Laurent Eckert(Sanofi (France)), Nikhil Amin(Regeneron (United States)), Neil M.H. Graham(Regeneron (United States)), Gianluca Pirozzi(Sanofi (United States)), Neil Stahl(Regeneron (United States)), George D. Yancopoulos(Regeneron (United States)), Brad Shumel(Regeneron (United States))
Cited by 1,234Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis